Wall Street Cool On Claritin Defense: Schering Prepares For Desloratadine

Schering-Plough's expected fourth quarter launch of desloratadine may serve as the next marker in Wall Street's assessment of patent defense strategies for the pharmaceutical industry.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet